Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Osteoarthritis Pain
Clinical trial NCT00312221 · TERMINATED
Trial details
- NCT number
- NCT00312221
- Sponsor
- Purdue Pharma LP
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-04-01
- Primary completion
- 2005-07-01
- Enrollment
- 418
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.